Laura Deming

Laura Deming is a prominent figure in the field of longevity research and investment. Here are some key details about her:

Background and Education

Laura Deming developed an interest in aging biology at a very young age. She began studying the subject at just 8 years old and started working in a lab at age 12.2 Deming was accepted to MIT at 14 to study physics, but later dropped out to accept the Thiel Fellowship and pursue her passion for longevity research.2

Career Highlights

• Founder and Partner at The Longevity Fund, a venture capital firm focused on aging and life extension.1
• Launched The Longevity Fund in 2011 at age 17 after receiving the Thiel Fellowship.2
• The fund has raised significant capital, including $4 million for its first fund and $22 million for its second fund in 2017.2
• In 2018, she launched Age1, a startup accelerator program for longevity companies.2
• Advisor to the Pioneer Fund, which aims to find talent in longevity research.2

Achievements and Recognition

• Featured in Forbes' "30 Under 30" list.2
• Appeared in National Geographic's documentary "The Age of Ageing".2
• Speaker at notable events like the Singularity Summit and TEDMED conference.2

Philosophy and Approach

Deming is passionate about using biological research to reduce or reverse the effects of aging.3 She believes that science can potentially create biological immortality in humans and has stated that ending aging "is a lot closer than you might think".2

Laura Deming's work at The Longevity Fund focuses on identifying and investing in pioneering science that holds promise for addressing age-related medical conditions.4 Her goal is to advance enterprises that can translate research into effective preclinical drug development programs.4